|

Diabetes Clinical Trials in New Orleans, LA

15 recruiting studies within 50 miles

Phase
Trial Phase Dist.
The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes)Phase 3<1 mi
Using a Telehealth and Shared Decision-Making Model to Address Preventative Medicine Strategies Among Communities in LouisianaN/A<1 mi
Strategies for Implementing a Postpartum Lifestyle Intervention in WIC ClinicsN/A<1 mi
Church-based Health Intervention to Eliminate Racial Inequalities in Cardiovascular HealthN/A<1 mi
Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM)—<1 mi
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)Phase 2<1 mi
Health Electronic Assessment of Risks and Trends Using Biometric Equipment and Technology—<1 mi
Different Doses of Naronapride Vs. Placebo in GastroparesisPhase 24 mi
Clinical Trial Assessing Human Placental Membrane Products and Standard of Care Versus Standard of Care in Nonhealing DFUs and VLUsN/A5 mi
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 DiabetesPhase 35 mi
VK2735 for Weight Management Type 2 Diabetes Phase 3 (VANQUISH 2)Phase 35 mi
A Study Called FINE-REAL to Learn More About the Use of the Drug Finerenone in a Routine Medical Care Setting—28 mi
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular DiseasePhase 328 mi
Amnio-Maxx in Patients With Diabetic Foot Ulcers Unresponsive to Standard of Care Treatment AloneN/A45 mi
Evaluating the Efficacy NeoThelium FT in the Treatment of Diabetic Foot UlcersN/A46 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.